Closed · HT9425-23-RTRP-CNA · CFDA 12.420 · Discretionary
DOD Reconstructive Transplant Clinical Network Award
Federal grant opportunity posted by Dept. of the Army -- USAMRAA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- February 1, 2023
- Close date
- 1
- Expected awards
The verdict
DOD Reconstructive Transplant Clinical Network Award is a closed discretionary listing from Dept. of the Army -- USAMRAA that offered Varies by applicant across 1 expected award. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 1
- expected award
- 12.420
- CFDA program
Opportunity snapshot. This Grants.gov announcement - DOD Reconstructive Transplant Clinical Network Award - is cataloged under number HT9425-23-RTRP-CNA and tied to CFDA assistance listing 12.420, posted by Dept. of the Army -- USAMRAA. Grants.gov currently shows the opportunity as closed, first posted on December 9, 2022 and last updated on December 12, 2022. The funding category is Discretionary, delivered as a other.
Award economics. The award range on file is Varies by applicant. The agency has projected $13.0 million in total estimated funding for this announcement. It expects to issue 1 award. If the agency funds the expected 1 award from the $13.0 million estimated pool, the average award works out to roughly $13.0 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on February 1, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
February 1, 2023
Posted
December 9, 2022
Est. Total Funding
$13,000,000
Expected Awards
1
Instrument
Other
Description
The RTRP Clinical Network Award mechanism was first offered in FY20, with awards to be made as grants or cooperative agreements. Three applications were received, but none were funded. This FY22 research announcement is being offered through a different type of award mechanism, a Research Other Transaction Award (rOTA) under the authority of 10 USC 4021.Statement on the Research Other Transaction Agreement: The principal purpose of a rOTA is to carry out non-duplicative basic, applied, and advanced research projects rather than the acquisition of property or services for the direct benefit or use of the government. The anticipated deliverables to the government under a rOTA are reports on research rather than prototypes.The rOTA requires resource sharing, with government funds not to exceed the total amount provided by other parties to the maximum extent practicable. Offerors will be required to demonstrate how resources (e.g., cash and non-cash) will be made available for this project. The rOTA is intended to promote the use of best business practices and to foster relationships among performers from different sectors.In addition, as a matter of DOD policy, rOTAs may only be awarded when one or more for-profit firms are to be involved either in the: (1) performance of the research project(s) or (2) commercial application of the research results. A consortium should either include, collaborate with, or involve one or more for-profit firms (e.g., pharmaceutical company to provide medication, rehabilitation clinic to provide services to recipients, etc.) in addition to state or local government agencies, institutions of higher education, or other nonprofit organizations. For the FY22 Clinical Network Award, the for-profit firm may be involved in either Phase 1, Phase 2, or both phases of the award.The government will enter into negotiations to finalize the terms and conditions of the anticipated Agreement with the presumptive awardee after applications are evaluated in accordance with Section III.B.1 and Section III.B.2 of this Research Announcement. A draft Agreement has been provided for informational purposes. The content of the draft Agreement reflects the government’s baseline terms and conditions for an expenditure-based rOTA and is subject to negotiation upon selection of the most advantageous offeror.General Information: The RTRP intends to allocate up to $13M to support the RTRP Clinical Network over 6 years, subject to availability of funding. This effort will be executed through a two-phase approach in the form of a single award to the Clinical Network Coordinating Center, hereby referred to as the Coordinating Center. The Coordinating Center will serve as the Clinical Network information and planning nexus, providing administrative, operational, and data management support services to implement Clinical Network activities in a timely manner. The period of performance for Phase 1 is 2 years, with maximum funding of $3M in RTRP funding for Coordinating Center costs. RTRP funding for the Phase 2 is contingent on successful completion of Phase 1 objectives and subject to the availability of funding. The period of performance for Phase 2 is 4 years, with maximum funding of $10M in RTRP funding for Coordinating Center costs and Network Site costs. The Coordinating Center will manage funding to the Network Sites through the execution of subaward agreements for Phase 1 and/or Phase 2 reimbursable activities and for other key collaborators. See Section I.E., Funding, for additional information.
Eligibility
Grants.gov lists this opportunity under eligibility category code 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Christopher Meinberg Agreements Officer Phone 3016192657
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Dept. of the Army -- USAMRAA
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
DOD Defense Health Agency (DHA) Research & Development FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
Department of Defense HIV/AIDS Prevention Program
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |